Full Content is available to subscribers

Subscribe/Learn More  >
Proceedings Article

Development and testing of an optoacoustic imaging system for monitoring and guiding prostate cancer therapies

[+] Author Affiliations
Gloria M. Spirou, I. Alex Vitkin, B. C. Wilson

Univ. of Toronto (Canada)

William M. Whelan

Ryerson Univ. (Canada)

Paul M. Henrichs, Ketan Mehta, Tom Miller, Andrew Yee, James Meador

Fairway Medical Technologies, Inc. (USA)

Alexander A. Oraevsky

Fairway Medical Technologies, Inc. (USA) and Rice Univ. (USA)

Proc. SPIE 5320, Photons Plus Ultrasound: Imaging and Sensing, 44 (July 12, 2004); doi:10.1117/12.535360
Text Size: A A A
From Conference Volume 5320

  • Photons Plus Ultrasound: Imaging and Sensing
  • Alexander A. Oraevsky; Lihong V. Wang
  • San Jose, CA | January 24, 2004

abstract

Laser Optoacoustic Imaging System (LOIS) combines high tissue contrast based on the optical properties of tissue and high spatial resolution based on ultrawide-band ultrasonic detection. Patients undergoing thermal or photodynamic therapy of prostate cancer may benefit from capability of LOIS to detect and monitor treatment-induced changes in tissue optical properties and blood flow. The performance of a prototype LOIS was evaluated via 2D optoacoustic images of dye-colored objects of various shapes, small tubes with blood simulating veins and arteries, and thermally coagulated portions of chicken breasts imbedded tissue-mimicking gelatin phantoms. The optoacoustic image contrast was proportional to the ratio of the absorption coefficient between the embedded objects and the surrounding gel. The contrast of the venous blood relative to the background exceeded 250%, and the contrast of the thermally coagulated portions of flesh relative to the untreated tissue ranged between -100% to +200%, dependent on the optical wavelength. We used a 32-element optoacoustic transducer array and a novel design of low-noise preamplifiers and wide-band amplifiers to perform these studies. The system was optimized for imaging at a depth of ~50 mm. The system spatial resolution was better than 1-mm. The advantages and limitations of various signal-processing methods were investigated. LOIS demonstrates clinical potential for non- or minimally-invasive monitoring of treatment-induced tissue changes.

© (2004) COPYRIGHT SPIE--The International Society for Optical Engineering. Downloading of the abstract is permitted for personal use only.
Citation

Gloria M. Spirou ; I. Alex Vitkin ; B. C. Wilson ; William M. Whelan ; Paul M. Henrichs, et al.
"Development and testing of an optoacoustic imaging system for monitoring and guiding prostate cancer therapies", Proc. SPIE 5320, Photons Plus Ultrasound: Imaging and Sensing, 44 (July 12, 2004); doi:10.1117/12.535360; http://dx.doi.org/10.1117/12.535360


Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).

Figures

Tables

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Book Chapters

Topic Collections

Advertisement
  • Don't have an account?
  • Subscribe to the SPIE Digital Library
  • Create a FREE account to sign up for Digital Library content alerts and gain access to institutional subscriptions remotely.
Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).
Access This Proceeding
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
Access This Chapter

Access to SPIE eBooks is limited to subscribing institutions and is not available as part of a personal subscription. Print or electronic versions of individual SPIE books may be purchased via SPIE.org.